Home » Drug Information » FDA Approved Drugs » 1996
Medical Areas: Ophthalmology | Infections and Infectious Diseases
View By:YearCompanyConditionsTherapeutic AreasDrug Names
AK-Con-A (naphazoline ophthalmic)
The following drug information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Approval Status: Approved January 1996
Treatment Area: antihistamine product
The over-the-counter version of AK-Con-A (naphazoline
ophthalmic) has been approved as a vasoconstrictor/antihistamine
product for opthalmic use. Naphazoline ophthalmic causes
decongestion in the eye by constricting blood vessels in the eye.
It also enlarges the pupil, and it reduces the amount of fluid in
the eye in two ways: It reduces the production of fluid inside the
eye, and it increases the amount of fluid that drains from the eye.
It is used to relieve redness, burning, irritation, and dryness of
the eye caused by wind, sun, and other minor irritants.
If you experience an allergic reaction (difficulty breathing;
closing of your throat; swelling of your lips, face, or tongue; or
hives); an irregular or fast heart rate; or high blood pressure
(severe headache, blurred vision, or flushed skin you should
immediately seek medical attention.
Less serious side effects include: burning, stinging, pain, or
increased redness of the eye; tearing or blurred vision; headache;
tremor; nausea; sweating; nervousness; dizziness; or drowsiness
Use naphazoline eye drops exactly as directed by your doctor, or
follow the directions that accompany the package. If you do not
understand these instructions, ask your doctor, pharmacist, or
nurse to explain them to you.
Naphazoline ophthalmic can be used up to four times a day--every
three to four hours. Do not use naphazoline ophthalmic more often
or over a longer period than is recommended. Overuse can cause
increased redness and irritation in the eye and can even lead to